Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis.

Lu YY, Chen JH, Chien CR, Chen WT, Tsai SC, Lin WY, Kao CH.

Int J Colorectal Dis. 2013 Aug;28(8):1039-47. doi: 10.1007/s00384-013-1659-z. Epub 2013 Feb 14. Review.

PMID:
23407908
2.

The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.

Ozkan E, Soydal C, Araz M, Kir KM, Ibis E.

Nucl Med Commun. 2012 Apr;33(4):395-402. doi: 10.1097/MNM.0b013e32834f7dbe.

PMID:
22367859
3.

The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.

Sanli Y, Kuyumcu S, Ozkan ZG, Kilic L, Balik E, Turkmen C, Has D, Isik G, Asoglu O, Kapran Y, Adalet I.

Ann Nucl Med. 2012 Aug;26(7):551-8. doi: 10.1007/s12149-012-0609-0. Epub 2012 May 30.

PMID:
22644560
4.

Does CEA and CA 19-9 combined increase the likelihood of 18F-FDG in detecting recurrence in colorectal patients with negative CeCT?

Panagiotidis E, Datseris IE, Rondogianni P, Vlontzou E, Skilakaki M, Exarhos D, Bamias A.

Nucl Med Commun. 2014 Jun;35(6):598-605. doi: 10.1097/MNM.0000000000000107.

PMID:
24681767
5.

Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.

Metser U, You J, McSweeney S, Freeman M, Hendler A.

AJR Am J Roentgenol. 2010 Mar;194(3):766-71. doi: 10.2214/AJR.09.3205.

PMID:
20173157
7.

Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations.

Kyoto Y, Momose M, Kondo C, Itabashi M, Kameoka S, Kusakabe K.

Ann Nucl Med. 2010 Jun;24(5):395-401. doi: 10.1007/s12149-010-0372-z. Epub 2010 Apr 3.

PMID:
20364373
8.

18F-FDG PET/CT superior to serum CEA in detection of colorectal cancer and its recurrence.

Makis W, Kurzencwyg D, Hickeson M.

Clin Imaging. 2013 Nov-Dec;37(6):1094-7. doi: 10.1016/j.clinimag.2013.04.004. Epub 2013 Aug 29.

PMID:
23993799
9.
10.

A systematic review and meta-analysis of pretherapeutic lymph node staging of colorectal cancer by 18F-FDG PET or PET/CT.

Lu YY, Chen JH, Ding HJ, Chien CR, Lin WY, Kao CH.

Nucl Med Commun. 2012 Nov;33(11):1127-33. Review.

PMID:
23000829
11.

Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer.

Caglar M, Yener C, Karabulut E.

Int J Comput Assist Radiol Surg. 2015 Jul;10(7):993-1002. doi: 10.1007/s11548-014-1115-8. Epub 2014 Sep 12.

PMID:
25213271
12.

18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis.

Wu LM, Hu JN, Hua J, Gu HY, Zhu J, Xu JR.

J Gastroenterol Hepatol. 2012 Mar;27(3):472-80. doi: 10.1111/j.1440-1746.2011.06919.x. Review.

PMID:
21916986
13.

FDG-PET scan in patients with clinically and/or radiologically suspicious colorectal cancer recurrence but normal CEA.

Sarikaya I, Bloomston M, Povoski SP, Zhang J, Hall NC, Knopp MV, Martin EW Jr.

World J Surg Oncol. 2007 Jun 7;5:64.

14.

Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level.

Lee JH, Park SG, Jee KN, Park DG, Namgung H, Song IH.

Nucl Med Commun. 2010 Jun;31(6):576-82. doi: 10.1097/MNM.0b013e32833845b7.

PMID:
20216474
15.

FDG PET or PET/CT for detecting intramedullary and extramedullary lesions in multiple Myeloma: a systematic review and meta-analysis.

Lu YY, Chen JH, Lin WY, Liang JA, Wang HY, Tsai SC, Kao CH.

Clin Nucl Med. 2012 Sep;37(9):833-7. doi: 10.1097/RLU.0b013e31825b2071. Review.

PMID:
22889770
16.

Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer: a systematic review and meta-analysis.

Chu Y, Zheng A, Wang F, Lin W, Yang X, Han L, Chen Y, Bai L.

Nucl Med Commun. 2014 Feb;35(2):144-50. doi: 10.1097/MNM.0000000000000026. Review.

PMID:
24177043
17.

18F-FDG PET or PET/CT for detecting extensive disease in small-cell lung cancer: a systematic review and meta-analysis.

Lu YY, Chen JH, Liang JA, Chu S, Lin WY, Kao CH.

Nucl Med Commun. 2014 Jul;35(7):697-703. doi: 10.1097/MNM.0000000000000122. Review.

PMID:
24694775
18.

Utility of 18-fluorodeoxyglucose positron emission/computed tomography in the management of recurrent colorectal cancer.

Liong SY, Kochhar R, Renehan AG, Manoharan P.

ANZ J Surg. 2012 Oct;82(10):729-36. doi: 10.1111/j.1445-2197.2012.06237.x. Epub 2012 Sep 18.

PMID:
22989147
19.

Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer.

Flanagan FL, Dehdashti F, Ogunbiyi OA, Kodner IJ, Siegel BA.

Ann Surg. 1998 Mar;227(3):319-23.

20.

Value of ¹⁸F-FDG PET-CT in surveillance of postoperative colorectal cancer patients with various carcinoembryonic antigen concentrations.

Zhang Y, Feng B, Zhang GL, Hu M, Fu Z, Zhao F, Zhang XL, Kong L, Yu JM.

World J Gastroenterol. 2014 Jun 7;20(21):6608-14. doi: 10.3748/wjg.v20.i21.6608.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk